CNS vs FHI: stock comparison and AI forecast
Cohen & Steers, Inc. (CNS) and Federated Hermes, Inc. (FHI) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CNS Cohen & Steers, Inc.
- Market Cap
- $3.76B
- P/E Ratio
- 22.9x
- Size
- mid-cap
- AI Forecast
FHI Federated Hermes, Inc.
- Market Cap
- $4.60B
- P/E Ratio
- 11.2x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- FHI is 1.2 times larger than CNS by market capitalization ($4.60B against $3.76B).
- FHI trades at 11.2 times trailing earnings, CNS at 22.9 times.
- CNS turns 28.2% of its revenue into net income, against 21.3% for FHI.
- FHI carries 0.78 times debt per unit of equity, against 0.38 times for CNS.
- CNS yields 3.60% in dividends and FHI 2.38%.
- Both companies share the SEC industry classification Investment Advice.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CNS | FHI |
|---|---|---|
| Market Cap | $3.76B | $4.60B |
| P/E Ratio | 22.85x | 11.24x |
| P/B Ratio | 6.19x | 3.56x |
| Dividend Yield | 3.60% | 2.38% |
| EPS | $3.20 | $5.53 |
| Book Value/Share | $11.81 | $17.46 |
| Revenue/Share | $11.66 | $26.67 |
| FCF/Share | – | $5.22 |
Profitability & Margins
| Metric | CNS | FHI |
|---|---|---|
| ROE | 27.8% | 32.5% |
| ROA | 17.2% | 17.0% |
| ROIC | – | 25.3% |
| Operating Margin | 32.4% | 27.8% |
| Net Margin | 28.2% | 21.3% |
| EBT Margin | 37.9% | 28.7% |
| Tax Rate | 42.2% | 25.6% |
Financial Health
| Metric | CNS | FHI |
|---|---|---|
| Current Ratio | – | 2.48x |
| D/E Ratio | 0.38x | 0.78x |
| Financial Leverage | 1.61x | 1.91x |
| Interest Coverage | – | 11.5x |
| Working Capital | – | $443M |
Cash Flow
| Metric | CNS | FHI |
|---|---|---|
| Operating Cash Flow | $38M | $405M |
| Free Cash Flow | – | $386M |
| Capital Spending | – | -$20M |
| OCF Growth YoY | – | 54.1% |
| FCF Growth YoY | – | 48.8% |
| FCF/Sales | – | 19.6% |
| CapEx/Sales | – | 1.0% |
Operational Efficiency
| Metric | CNS | FHI |
|---|---|---|
| Asset Turnover | 0.61x | 0.80x |
| Fixed Assets Turnover | 10.2x | 40.1x |
Income Statement
| Metric | CNS | FHI |
|---|---|---|
| Total Revenue | $600M | $1.97B |
| Operating Income | $194M | $548M |
| Net Income | $169M | $420M |
Dividend & Shareholder Information
| Metric | CNS | FHI |
|---|---|---|
| Dividends Per Share | $2.63 | $1.48 |
| Payout Ratio | 82.2% | 26.8% |
| Shares Outstanding | 51M | 74M |
| Net Income Growth | 2.9% | 10.1% |
| EPS Growth | 3.2% | -3.3% |
CNS vs FHI: stock comparison and AI forecast
Which is bigger, CNS or FHI?
FHI is 1.2 times larger than CNS by market capitalization ($4.60B against $3.76B).
Which is cheaper on earnings, CNS or FHI?
FHI trades at 11.2 times trailing earnings, CNS at 22.9 times.
Which one does Intratio's AI model rank higher, CNS or FHI?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.